Cargando…
Low GSTM3 expression is associated with poor disease‐free survival in resected esophageal squamous cell carcinoma
BACKGROUND: Glutathione S-transferase mu 3 (GSTM3) plays a crucial role in tumor progression in various cancers. However, the relationship between GSTM3 expression and the clinical prognosis of esophageal squamous cell carcinoma (ESCC) has not been studied to date. We aimed to characterize the role...
Autores principales: | Yang, Fu, Wen, Jing, Luo, Kongjia, Fu, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821639/ https://www.ncbi.nlm.nih.gov/pubmed/33482859 http://dx.doi.org/10.1186/s13000-021-01069-4 |
Ejemplares similares
-
Smoking Affects Treatment Outcome in Patients with Resected Esophageal Squamous Cell Carcinoma Who Received Chemotherapy
por: Zheng, Yuzhen, et al.
Publicado: (2015) -
A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio
por: Tan, Zihui, et al.
Publicado: (2017) -
miR-424 coordinates multilayered regulation of cell cycle progression to promote esophageal squamous cell carcinoma cell proliferation
por: Wen, Jing, et al.
Publicado: (2018) -
NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression
por: Chen, Junying, et al.
Publicado: (2015) -
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
por: Wen, Jing, et al.
Publicado: (2022)